Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRASH-3 trial of tranexamic acid in significant traumatic brain injury
2011-003669-14Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: In-hospital death within 28 days of injury and Cause-specific mortality. Started Jun 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2011-003669-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003669-14.